Informa Healthcare – one of the world’s leading medical and scientific publishers – has released its latest Journal Impact Factor* results, with outstanding performances across the division’s diverse selection of peer-reviewed journals.
Highlights included Critical Reviews in Biochemistry and Molecular Biology, which registered a staggering 10.216 Impact Factor, up 23% from 8.306 last year; The World Journal of Biological Psychiatry, increased more than 55% to 5.564; and Chronobiology International jumped up to 3.987.
Impact Factors are a method of measuring the influence which a journal has on the scientific community. They are calculated by Thomson Reuters and are designed to indicate how many times the published articles of a journal are cited during the course of a year, providing an insight to how much ‘impact’ the journal is making on the scientific community.
“The Impact Factor can help validate the importance of our journals to the medical and scientific communities we serve,” explains Phil Garner, Divisional Managing Director at Informa Healthcare.
“We are extremely proud of the high quality information which we publish for our readers and the wide range of healthcare fields covered by our titles. We are delighted that this year’s Impact Factor increases for each journal clearly reflect the quality and importance of the research and pinpoint how much it is being used throughout the year”
Informa’s Expert Opinion series – which provides in-depth analysis of the pharmaceutical R&D pipeline – has registered noteworthy performances in Expert Opinion on Investigational Drugs which increased its Impact Factor to 4.218, and Expert Opinion on Drug Delivery which impressed with a first-ever Impact Factor of 3.345.
“These results demonstrate the comprehensive, intelligent content that makes our Expert Opinion journals the definitive reference source for leading pharmaceutical scientists,” says Phil.
Four other Informa titles to enter the market with a remarkable impact include: Journal of Immunotoxicology with a first-ever impact factor of 1.218; Computer Aided Surgery with an impact factor of 1.221; Logopedics, Phoniatrics Vocology had a 1.175 Impact Factor in its first year; and Australasian Psychiatry entering the market at 0.657.
“We are justifiably proud of the performance of all of our journals,” adds Phil. “Our established journals have continued to move from strength to strength, with many titles solidifying an upward trend in their respective rankings.”
The World Journal of Biological Psychiatry moved up 22 places in the Psychiatry category, while the Amyotrophic Lateral Sclerosis Impact Factor increased 63% to 2.963, moving 37 places up within its Clinical Neurology sector. The Scandinavian Journal of Primary Health Care also moved up 13 places with a 27.9% Impact Factor increase to 2.205.
Other titles that registered impressive Impact Factor performances were: Cancer Investigation, with an increased impact factor of 2.105; Autoimmunity at 2.813; Critical Reviews in Microbiology with 3.207; Leukemia & Lymphoma at 2.397; and Nanotoxicology which registered a 72.5% increase to 5.774.
“Our overall performance – together with the outstanding individual performances of many of our titles – ensures that Informa continues to serve as a leading force in medical and scientific publishing, providing the market with the lion’s share of must-read titles,” explains Phil.
*© Thomson Reuters, Journal Citation Reports® 2010
Tuesday 22 June 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment